Nuvation Bio Inc.
NUVB · NYSE
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | — | — | -119.73M | -104.20M | -0.48 |
| 2023 FY | — | — | -99.82M | -75.80M | -0.35 |
| 2024 FY | 7.87M | 795.00K | -592.63M | -567.94M | -2.11 |
| 2025 FY | 62.90M | 54.46M | -213.06M | -204.63M | -0.60 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 672.14M | 17.07M | 101.10M | 4.26M | 655.08M |
| 2023 FY | 621.48M | 16.36M | 42.65M | 4.01M | 605.12M |
| 2024 FY | 540.63M | 76.84M | 35.72M | 8.92M | 463.79M |
| 2025 FY | 594.82M | 289.11M | 164.09M | 10.15M | 305.72M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -96.11M | -370.00K | -96.48M | — | -31.32M |
| 2023 FY | -68.00M | -69.00K | -68.07M | — | -58.45M |
| 2024 FY | -130.41M | -162.00K | -130.58M | — | -6.93M |
| 2025 FY | -173.43M | -354.00K | -173.78M | — | 128.36M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 416.10M | 319.27M | — | — | — |
| 2023 FY | 330.51M | 291.87M | — | — | — |
| 2024 FY | 714.93M | 688.13M | — | — | — |
| 2025 FY | 3.06B | 2.91B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 4.83M | 2.26M | -63.59M | -59.01M | -0.17 |
| 2025 Q3 | 13.12M | 9.77M | -56.43M | -55.79M | -0.16 |
| 2025 Q4 | 41.87M | 41.44M | -34.04M | -36.59M | -0.11 |
| 2026 Q1 | 83.23M | 77.61M | 3.88M | 5.40M | 0.02 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 647.23M | 274.32M | 247.97M | 57.76M | 372.91M |
| 2025 Q3 | 601.56M | 275.68M | 98.90M | 57.55M | 325.88M |
| 2025 Q4 | 594.82M | 289.11M | 164.09M | 10.15M | 305.72M |
| 2026 Q1 | 610.24M | 290.68M | 125.39M | 9.83M | 319.56M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | -48.18M | -181.00K | -48.36M | — | 199.99M |
| 2025 Q3 | -52.89M | -12.00K | -52.90M | — | -149.07M |
| 2025 Q4 | -29.73M | -89.00K | -29.82M | — | 65.19M |
| 2026 Q1 | 5.07M | -48.00K | 5.02M | — | -38.70M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 664.45M | 474.25M | — | — | — |
| 2025 Q3 | 1.27B | 1.23B | — | — | — |
| 2025 Q4 | 3.09B | 2.93B | — | — | — |
| 2026 Q1 | 1.49B | 1.37B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |